Literature DB >> 23220634

Overexpression of methyl-CpG binding protein 2 impairs T(H)1 responses.

Tianshu Yang1, Melissa B Ramocki, Jeffrey L Neul, Wen Lu, Luz Roberts, John Knight, Christopher S Ward, Huda Y Zoghbi, Farrah Kheradmand, David B Corry.   

Abstract

The DNA binding protein methyl-CpG binding protein 2 (MeCP2) critically influences neuronal and brain function by modulating gene expression, and children with overexpression of the MECP2 gene exhibit postnatal neurological syndromes. We demonstrate that some children with MECP2 duplication also display variable immunological abnormalities that include reductions in memory T and B cells and natural killer cells and immunoglobulin assay responses. Moreover, whereas mice with MeCP2 overexpression were unable to control infection with the intra-macrophage parasite Leishmania major and secrete interferon-γ (IFN-γ) from involved lymph nodes, they were able to control airway fungal infection by Aspergillus niger and mount protective T helper cell type 2 (T(H)2)-dependent allergic responses. Relative to normal T cells, T(H) cells from children and mice with MECP2 duplication displayed similar impairments in IFN-γ secretion and T(H)1 responses that were due to both MeCP2-dependent suppression of IFN-γ transcription and sequestration of the IFN-γ locus as assessed by chromatin immunoprecipitation assay. Thus, overexpressed MeCP2 aberrantly suppresses IFN-γ secretion from T(H) cells, potentially leading to a partially immunodeficient state. Our findings establish a rational basis for identifying, treating, and preventing infectious complications potentially affecting children with MECP2 duplication.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23220634      PMCID: PMC3628825          DOI: 10.1126/scitranslmed.3004430

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  44 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

2.  Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation.

Authors:  Philippe T Georgel; Rachel A Horowitz-Scherer; Nick Adkins; Christopher L Woodcock; Paul A Wade; Jeffrey C Hansen
Journal:  J Biol Chem       Date:  2003-06-04       Impact factor: 5.157

3.  Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA.

Authors:  R R Meehan; J D Lewis; A P Bird
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

4.  Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation.

Authors:  Mona D Shahbazian; Barbara Antalffy; Dawna L Armstrong; Huda Y Zoghbi
Journal:  Hum Mol Genet       Date:  2002-01-15       Impact factor: 6.150

5.  Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis.

Authors:  D B Corry; S L Reiner; P S Linsley; R M Locksley
Journal:  J Immunol       Date:  1994-11-01       Impact factor: 5.422

6.  IL-1 receptor-associated kinase 1 regulates susceptibility to organ-specific autoimmunity.

Authors:  Caishu Deng; Caius Radu; Asim Diab; May F Tsen; Rehana Hussain; John S Cowdery; Michael K Racke; James A Thomas
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

7.  A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease.

Authors:  Farrah Kheradmand; Attila Kiss; Jie Xu; Seung-Hyo Lee; Pappachan E Kolattukudy; David B Corry
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

8.  Mild overexpression of MeCP2 causes a progressive neurological disorder in mice.

Authors:  Ann L Collins; Jonathan M Levenson; Alexander P Vilaythong; Ronald Richman; Dawna L Armstrong; Jeffrey L Noebels; J David Sweatt; Huda Y Zoghbi
Journal:  Hum Mol Genet       Date:  2004-09-06       Impact factor: 6.150

9.  Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells.

Authors:  T L Stevens; A Bossie; V M Sanders; R Fernandez-Botran; R L Coffman; T R Mosmann; E S Vitetta
Journal:  Nature       Date:  1988-07-21       Impact factor: 49.962

10.  Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome.

Authors:  Rodney C Samaco; Caleigh Mandel-Brehm; Christopher M McGraw; Chad A Shaw; Bryan E McGill; Huda Y Zoghbi
Journal:  Nat Genet       Date:  2012-01-08       Impact factor: 38.330

View more
  29 in total

Review 1.  Natural killer cell deficiency.

Authors:  Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-09       Impact factor: 10.793

Review 2.  Emerging insights into human health and NK cell biology from the study of NK cell deficiencies.

Authors:  Emily M Mace; Jordan S Orange
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 3.  When the balance is broken: X-linked gene dosage from two X chromosomes and female-biased autoimmunity.

Authors:  Camille M Syrett; Montserrat C Anguera
Journal:  J Leukoc Biol       Date:  2019-05-24       Impact factor: 4.962

4.  MeCP2 reinforces STAT3 signaling and the generation of effector CD4+ T cells by promoting miR-124-mediated suppression of SOCS5.

Authors:  Shan Jiang; Chaoran Li; Gabrielle McRae; Erik Lykken; Jose Sevilla; Si-Qi Liu; Ying Wan; Qi-Jing Li
Journal:  Sci Signal       Date:  2014-03-11       Impact factor: 8.192

5.  Influenza A induces dysfunctional immunity and death in MeCP2-overexpressing mice.

Authors:  James C Cronk; Jasmin Herz; Taeg S Kim; Antoine Louveau; Emily K Moser; Ashish K Sharma; Igor Smirnov; Kenneth S Tung; Thomas J Braciale; Jonathan Kipnis
Journal:  JCI Insight       Date:  2017-01-26

Review 6.  Unexpected cellular players in Rett syndrome pathology.

Authors:  James C Cronk; Noel C Derecki; Vladimir Litvak; Jonathan Kipnis
Journal:  Neurobiol Dis       Date:  2015-05-14       Impact factor: 5.996

Review 7.  Contributions of monocytes to nervous system disorders.

Authors:  Juan Mauricio Garré; Guang Yang
Journal:  J Mol Med (Berl)       Date:  2018-07-21       Impact factor: 4.599

8.  Brief report: regression timing and associated features in MECP2 duplication syndrome.

Authors:  S U Peters; R J Hundley; A K Wilson; C M B Carvalho; J R Lupski; M B Ramocki
Journal:  J Autism Dev Disord       Date:  2013-10

9.  Overexpression of methyl-CpG-binding protein 2 and autoimmunity: evidence from MECP2 duplication syndrome, lupus, MECP2 transgenic and Mecp2 deficient mice.

Authors:  A H Sawalha
Journal:  Lupus       Date:  2013-07-16       Impact factor: 2.911

Review 10.  MECP2 disorders: from the clinic to mice and back.

Authors:  Laura Marie Lombardi; Steven Andrew Baker; Huda Yahya Zoghbi
Journal:  J Clin Invest       Date:  2015-08-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.